We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.00 | -0.35% | 282.60 | 282.60 | 283.00 | 283.20 | 279.80 | 281.80 | 4,198,441 | 16:29:55 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 44.43 | 5.79B |
From Apr 2019 to Apr 2024
TIDMCTEC
RNS Number : 2491D
ConvaTec Group PLC
25 June 2019
BOARD CHANGE
Reading, United Kingdom (25 June 2019) - Jesper Ovesen has advised the Board of ConvaTec Group Plc ("ConvaTec" or "the Company") that he wishes to retire as a Non-Executive Director of the Company on 28(th) June 2019.
Margaret Ewing, Senior Independent Director, will succeed Jesper as Chair of the Audit and Risk Committee and Regina Benjamin will also become a member of the Committee. Regina will also be appointed as a member of the Remuneration Committee. These appointments will take effect from 28(th) June.
Margaret joined the Board of ConvaTec in August 2017. She has strong executive and non-executive experience with large listed businesses and is currently a Non-Executive Director and Chair of the Audit and Risk Committee of ITV plc and a Non-Executive Director and member of the Audit and Compliance Committee of International Airlines Group plc. She was previously CFO of BAA plc and Trinity Mirror plc and Executive Board member of Deloitte LLP.
Rick Anderson, Executive Chairman, commented "On behalf of the Board I would like to thank Jesper for his valuable contribution to ConvaTec since he became a Director in 2016.
We are very pleased that Margaret has agreed to become the Chair of the Audit and Risk Committee, where her knowledge and experience will be most valuable to ConvaTec."
This announcement is made in accordance with Listing Rule 9.6.11R(1).
Enquiries:
Analysts and Investors John Crosse, VP Investor Relations +44 (0)7500 141435 Mark Reynolds, Director Investor Relations investorrelations@convatec.com +44 (0)7551 036625 Media Bobby Leach, VP Group Corporate Affairs +44 (0)7770 842226 Finsbury +44 (0)207 2513801
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAFIMATMBATBML
(END) Dow Jones Newswires
June 25, 2019 02:01 ET (06:01 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
